|
Index of reports
> Cases resulting in hospitalization (57)
> Cases with Ventricular Fibrillation (3)
Below is the selection of adverse event reports related to Botox (Botulinum Toxin Type A) that includes cases resulting in hospitalization where reactions include ventricular fibrillation.
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from Canada on 2007-06-04
Patient: male, weighing 73.9 kg (162.6 pounds)
Adverse reactions / side effects: Grand MAL Convulsion, Coma, Acute Respiratory Distress Syndrome, Ventricular Fibrillation, Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Other drugs received by patient: Lamotrigine; Wellbutrin
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from Canada on 2007-05-08
Patient: male
Adverse reactions / side effects: Grand MAL Convulsion, Coma, Acute Respiratory Distress Syndrome, Ventricular Fibrillation
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Other drugs received by patient: Lamotrigine; Wellbutrin
Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from South Africa on 2007-02-20
Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Back Pain, Guillain-Barre Syndrome, Nausea, Hypotension, Muscular Weakness, Organ Failure, Brain Oedema, Dizziness, Pulmonary Oedema, Cytomegalovirus Infection, Respiratory Arrest, Ventricular Fibrillation, Cardiac Arrest, Muscle Spasms, Lung Injury
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Botox
Dosage: 22 units, single
Indication: Skin Wrinkling
Start date: 2006-07-27
End date: 2006-07-27
Botox
Dosage: 22 units, single
Start date: 2006-10-25
End date: 2006-10-25
Other drugs received by patient: Natrilix / 00340101 /; Diane
|
